Study of a medicine to treat high potassium in children
Part of Hormones & metabolism clinical trials.
This trial tests how safe and effective SZC is for children with high potassium levels (hyperkalaemia) over the short term, and possibly long term. It aims to help lower potassium safely and see whether it works well in different pediatric age groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be from birth up to under 18 years old during the study
- Your child must have high potassium that meets the trial’s lab and urine/blood criteria
- At screening, an ECG (heart tracing) must meet age-specific limits for “QTc” timing
- Your child must be able to have repeated blood draws, or blood can be taken via an IV/vein line
- If your child can become pregnant: they must have a negative pregnancy test and use two reliable birth-control methods
- They must not have certain causes of high potassium (for example, dehydration or specific medication causes) and must not need immediate heart treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a medication called patiromer, combined with a low-potassium diet, can help manage potassium levels in people on chronic dialysis. The goal is to improve quality of life by allowing a more flexible diet.
This study looks at whether using an AI tool on ECG (heart tracing) can help doctors decide the best timing for giving medicine to lower high potassium levels in the emergency department. If you have high potassium, this could help guide your treatment to keep your heart safe.
This trial tests a new study drug called AZD1613 for adults with a certain type of kidney disease (ADPKD). Researchers want to see if it is safe, how the body handles it, and what the right dose might be.
This trial tests a medication (SZC) that helps lower high potassium levels, so you can keep taking important heart and kidney drugs (RAASi/MRA). It is for people with heart failure and chronic kidney disease who have high potassium.
This trial tests whether closely managing potassium levels during hemodialysis can help protect the heart in patients with kidney failure who are on maintenance dialysis. It aims to reduce the risk of heart problems related to potassium swings.
This study tests a medicine called patiromer, which helps lower high potassium levels in the blood. It is for children under 12 who have high potassium that needs treatment for at least a month.
Hear when a new Hyperkalaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.